Conclusion We should continue to make efforts on post-marketing assessment.
结论应继续深入开展药品上市后评价工作。
Provide assessment of safety issues arising in clinical trials or in the post-marketing setting and escalate those to the line manager within the organization or/and client.
对临床试验或上市后产生的安全问题提供评估，并且将这些安全问题递交给组织内的部门经理和客户。
Post-marketing drug assessment is now onset in our country, and the research is unsubstantial.
我国的药品上市再评价刚起步，在该领域的研究非常薄弱。
应用推荐